Semester 1 Pharmacology Flashcards

1
Q

What is the definition of a receptor?

A

It is a macromolecular component of a cell with which a drug interacts to produce its characteristic biological effect

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What concentrations are receptors present in?

A

Receptors are present in low concentrations and show saturable binding

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Receptor binding

A

Displays saturable binding

Saturable binding means that as you increase the amount of drug inside of the tissue, there will be an increase in the amount of receptors that have been bound to, until all receptors have been bound

Has a maximum binding, due to a finite number of binding sites

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What affinity do drugs have for receptors?

A

Many drugs have high affinities for their receptors, meaning a drug will bind to its receptors at low concentrations

Affinity is measured using the equilibrium dissociation constant Kd

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Do receptors show selectivity?

A

Receptors show strong selectivity

Sometimes referred to as a pharmacological profile

Each receptor has an order of affinity for each drug that reacts with the receptor

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Are drug-receptor interactions reversible?

A

Drug-receptor interactions are usually fully reversible, neither the drug nor the receptor are permanently changed

Drug + Receptor <–> DR

A few exceptions:
- Toxins (bind so tightly that its irreversible)
- Phenoxybenzamine (Used to treat tumour of Adrenal Medulla)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What size are drugs?

A

Drugs are usually very small molecules

Their molecular weights are typically 200 (compared to typical -250,000 for receptor)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What is special about a receptors binding site?

A

A receptors binding site has a complementary structure to the drug

Drugs are only held by week bonds so a close fit is required

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

How do agonists effect receptors?

A

Agonists induce conformational change in their receptors

Receptors are not rigid

This ‘induced fit’ has been confirmed by structural biology

ANTAGONISTS do NOT cause conformational change

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

How can we quantify drug-receptor interactions?

A

To allow comparison between drugs their effects must be quantified:

  1. ASSUME LAW OF MASS ACTION
    - D + R = DR
    - Rate of forward reaction = k[D][R]
    - Rate of reverse reaction = k-1[DR]
  2. ASSUME ONLY NEGLIGIBLE AMOUNT OF DRUG IS BOUND
    - Free drug = total drug
  3. ASSUME REACTION IS AT EQUILIBRIUM
    - k1[D][R] = k-1[DR]
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What is the equation that allows you to derive the equilibrium dissociation constant of a drug for its receptor?

A

The langmuir equation!

Will result in a rectangular hyperbola

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What is special about Kd and half fractional occupancy

A

The concentration of the drug at which you are receiving half maximal receptor occupancy is equal to Kd

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What is special about nicotinic receptors?

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

How does occupancy relate to biological effect?

A

2 theories:

Occupation theory:
- Response [E] is directly proportional to the number of receptors occupied

Rate theory:
- Response [E] is directly proportional to the rate of receptor occupation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Occupation theory equation and explanation

A

More receptors binded the larger the response

Maximal response at full binding

Graphs of fractional response against drug concentration will have same shape as fractional occupancy against drug concentration

Therefore at the half maximal response, the [D] will equal the Kd

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What is pD2?

A

pD2 is the negative log of the agonist concentration that gives a half maximal response

It is a very useful pharmacological parameter as it quantifies the affinity of an agonist for its receptor

Drugs with high values of pD2 act at low concentrations

pD2 is always positive and there are no units

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

How do we measure pD2?

A

From a log[concentration] response curve:

Take the negative log of the concentration of agonist that gives a half maximal response (EC50)

-log(EC50)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

What is a competitive antagonist?

A

The agonist and antagonist bind to the same site

The block can be overcome by increasing the concentration of the agonist

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

What is a non-competitive antagonist?

A

The antagonist binds to a different site on the receptor, or acts irreversibly

The block CANNOT be overcome by increasing the concentration of agonist

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Competitive antagonism graph differences

A
  • Dose response curve shifts to the right in a parallel fashion
  • The apparent pD2 decreases in the presence of the competitive antagonis
  • There is no change in Emax (maximal response)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Non competitive antagonism graph differenes

A
  • The pD2 is not changes
  • Emax decrease (maximum response)
  • Dose-response curves are not parallel
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

What does the ability to block a response depend on for a competitive antagonist?

A
  • The relative affinity of the agonist (Kd) and the relative affinity of the antagonist (Ka) for the receptor
  • The relative concentrations of the agonist [D] and the antagonist [A]
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Fractional occupancy in the presence of agonist and antagonist equation

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

What is a dose ratio?

A

It is the ratio of the agonist concentrations that elicit the same response either in the absence [Do] or the presence of [Da] the antagonist

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

What is an assumption we can make about dose ratio?

A

If the response in the presence of and absence of the antagonist is the same, then it is reasonable to assume that the occupancy by the agonist is the same

This concept is used to derive the affinity of antagonists from dose-response curves

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

How can you use a series of dose response curves in the presence and absence of an antagonist to determine the antagonist affinity?

A
  • Choose any response (usually 50%)
  • Determine the agonist concentrations that give this response in the absence [Do] and presence [D1, D2…] of antagonist concentrations A1, A2…
  • Calculate the dose ratio D1/D0, D2, D0… at each antagonist concentration
  • Use the Gaddum-Schild Equation
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
27
Q

What is the Gaddum-Schild Equation?

A

Analysis is based off of the law of mass action and assumes simple competitive antagonism

No assumptions are made about the relationship between response and the number of receptors occupied

It is independent of the agonist used - so long as it competes with the antagonist for the same receptor

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
28
Q

Watch first 10 minutes of LHD RECEPTORS IV OCT 16TH

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
29
Q

What do different pA2 values mean?

A

Higher the pA2 value, the stronger the affinity the antagonist has on the receptor

In the example shown, more atropine will be required in histamine receptors than acetylcholine receptors as the affinity for the histamine receptors is lower…

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
30
Q

How is pA2 measured?

A

pA2 = -log(Ka)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
31
Q

What are the assumptions of the occupancy theory?

A
  1. There are specific receptors for specific agonists
  2. All agonists for a given receptor can produce the same maximum response
  3. The drug-receptor interaction is rapidly reversible
  4. All receptors are equally accessible to the drug
  5. The receptors do not interact with each other
  6. The maximum response occurs when all receptors are occupied
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
32
Q

What did Stephenson (1956) discover?

A

He found that some agonist drugs act on receptors and only produce a weak response (partial agonist)

He described the action of n-alkyltrimethylammonium compounds on the guinea pig ileum

n = 4-6 full agonist
n = 7-9 partial agonist

Partial agonists act as competitive antagonists of the full agonist

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
33
Q

Do all drugs produce the same effect when bound to the same receptor?

A

No

Drugs may differ in their ability to induce a conformational change in the receptor, once they have bound

D + R <–> DR <–> DR*

DR = Affinity
DR* = Ability to produce an effect (intrinsic activity - alpha)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
34
Q

What are “spare receptors” in pharmacology?

A

Spare receptors are the subset of receptors that remain unoccupied, yet the system still elicits a maximal response

They amplify tissue or system sensitivity: a significant response can be achieved even with low ligand concentrations

Serve as a protective mechanism, offering a buffer against scenarios of receptor loss or downregulation

Emphasise the dissociation between receptor occupancy and physiological response, showing a non-linear relationship

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
35
Q

Why are spare receptors crucial in pharmacology and drug design?

A

Maximal effect (Emax) can be achieved even if not all receptors are occupied

Relevant primarily for agonists; antagonists often need to occupy more receptors to counteract endogenous ligands

Drugs acting on systems with spare receptors might be effective at low doses

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
36
Q

What is a “spare receptors knockout test” in pharmacology?

A

A test designed to determine the presence and extent of spare receptors in a system

Method involves reducing the number of functional receptors, often through genetic modification or by using antagonists

If a maximal response can still be achieved after reducing the receptor number, it indicates the presence of spare receptors

Provides insights into the relationship between receptor occupancy and physiological response, as well as the system’s sensitivity to agonists

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
37
Q

Will an agonist bind to a receptors active or rested state?

A

An agonist with high efficacy will preferentially bind to 2
and stabilise the active conformation of the receptor

An agonist with low efficacy may bind to both 1 and 2

An antagonist will only bind to 1

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
38
Q

What are inverse agonists and where did the concept originate?

A

The concept originated from studies on anxiolytics and anxiogenics (benzodiazepines) that work through the GABA-A receptor

Some receptors have some activity in the resting state – constitutive activity

This is reversed by inverse agonists, which decrease the basal activity

This is a wide-spread phenomenon also applies to GPCRs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
39
Q

What are the main types of agonists in pharmacology?

A

Full Agonist:
- Binds to and fully activates the receptor, eliciting a maximal physiological response

Partial Agonist:
- Binds to the receptor but only induces a sub-maximal response, even when occupying all receptors

Inverse Agonist:
- Binds to and stabilises the receptor in an inactive conformation, decreasing its basal activity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
40
Q

What is the autonomic nervous system?

A

ANATOMICALLY it is defined as all those neural pathways that leave the brain that do not innervate the voluntary muscles

PHYSIOLOGICAL ROLE: Homeostasis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
41
Q

Organization of the nervous system

A

Two main sections:
- CNS
- PNS

Under PNS also two main sections:
- Somatic
- Autonomic

Under Autonomic also two main sections:
- Sympathetic
- Parasympathetic

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
42
Q

What is homeostasis and how is it controlled?

A

Homeostasis is defined as a self-regulating process by which a living organism can maintain internal stability while adjusting to changing external conditions

After sensory input homeostasis is controlled by 2 factors:
- Neuronal response (ANS) (faster response)
- Hormonal response (Hypothalamus) (more sustained response)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
43
Q

What are the differences between the two types of autonomic nervous system?

A

Sympathetic (Fight or Flight)

Parasympathetic (Rest and Digest)

These two cannot coexist, only ever sympathetic or parasympathetic at one time

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
44
Q

What are the Physiological roles of Autonomic Nervous System?

A

Important in regulation of:

  • Pupillary dilation
  • Accommodation for near vision
  • Dilation and constriction of blood vessels
  • Force and rate of heart beat
  • Movements of the gastrointestinal tract
  • Secretions from most glands
  • Energy metabolism, particularly in liver and skeletal muscle
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
45
Q

What is a ganglion?

A

The point of contact between the first and second efferent neurone in the pathway occurs in a neural structure called a GANGLION

A GANGLION is a group of nerve cell bodies that lie outside the central nervous system

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
46
Q

What are the differences in the preganglionic and postganglionic nerves in the para and sympathetic ns?

A

Sympathetic has:
- short preganglionic nerve
- long postganglionic nerve

Parasympathetic has:
- long preganglionic nerve
- short postganglionic nerve

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
47
Q

Names of drugs that influence the ANS?

A

Mimic or block the effects of the two primary neurotransmitters:
- Acetylcholine
- Norepinephrine/Epinephrine

Drugs that mimic neurotransmitters are referred to as:
- Receptor agonists
- These drugs activate receptors

Drugs that block neurotransmitters are referred to as:
- Receptor antagonists
- These drugs block the endogenous neurotransmitters from activating receptors

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
48
Q

Structure and function of sympathetic nervous system?

A
  • Innervates many different tissues
  • Preganglionic neurone located in midbrain, medulla or lateral horn of spinal cord
  • Ganglia form the ‘sympathetic chain’
  • Short preganglionic neurone
  • Long postganglionic neurone
  • Provides diffuse innervation of target tissues
49
Q

Structure and function of parasympathetic nervous system?

A
  • Innervates many different tissues
  • Preganglionic neurone located in medulla or sacral segment of spinal cord
  • Ganglia are located in the target tissue
  • Long preganglionic neurone
  • Short postganglionic neurone
  • Provides discrete innervation of target tissues
50
Q

What is the central control of the ANS?

A

Amygdala:
- Main limbic region for emotions

Hypothalamus:
- Main integration centre

Reticular formation:
- Most direct influence over autonomic function

51
Q

What are some exceptions in the ANS?

A

Kidneys:
- Postganglionic neurons to the smooth muscle of the renal vascular bed release dopamine

Adrenal gland:
- Preganglionic neurons do not synapse in the paraverterbral sympathetic ganglion

  • Preganglionic neurons synapse directly on the adrenal gland, release acetylcholine, and activate nicotinic receptors on the adrenal gland
  • Adrenal glands release epinephrine into systemic circulation
52
Q

What neurotransmitter is involved in excitatory transmission at ALL autonomic ganglia (both sympathetic and parasympathetic) and which receptor does it act on?

A

The neurotransmitter is Acetylcholine and it acts on Nicotinic acetylcholine receptors

53
Q

At the postganglionic sympathetic synapse, which neurotransmitter is usually involved and on which receptors does it act?

A

The neurotransmitter is Noradrenaline and it acts on either α-adrenoceptors or β-adrenoceptors

54
Q

What neurotransmitter is involved in transmission at the postganglionic parasympathetic synapse and which receptor does it act on?

A

The neurotransmitter is Acetylcholine and it acts on Muscarinic receptors

55
Q

What does it mean to have antagonistic inputs for sympathetic and parasympathetic ANS?

A
56
Q

What is the enteric nervous system?

A
  • Consists of neurones that regulate the gastrointestinal tract
  • It receives inputs from the sympathetic and parasympathetic nervous system
  • It is neurochemically and functionally complex
  • It expresses a wide diversity of neurotransmitters
  • It expresses mechanoreceptors and chemoreceptors and is involved in local reflex pathways that regulate the activity of the gut independent of neural input from higher centres
57
Q

What are some dysautonomia/autonomic dysfunction?

A
  • Dizziness and fainting upon standing up, or (or intolerance) orthostatic hypotension
  • An inability to alter heart rate with exercise
  • Sweating abnormalities
  • Digestive difficulties, such as a loss of appetite, bloating, diarrhea, constipation, or difficulty swallowing
  • Urinary problems, such as difficulty starting urination, incontinence, and incomplete emptying of the bladder
  • Sexual problems in men, such as difficulty with ejaculation or maintaining an erection
  • Sexual problems in women, such as vaginal dryness or difficulty having an orgasm
  • Vision problems, such as blurry vision or an inability of the pupils to react to light quickly
58
Q

History of the discovery of transmission at the post-ganglionic sympathetic synapse

A

Historical:

  • Adrenaline was identified from adrenal extracts
  • Adrenaline was shown to mimic sympathetic nerve stimulation
  • The Finkelman preparation provided evidence that the sympathetic nervous system releases an adrenaline like compound
  • Von Euler demonstrated that nor-adrenaline is the main endogenous catecholamine in the sympathetic nerves
59
Q

What are the exceptions of noradrenaline being the main transmitter in post-ganglionic sympathetic synapses?

A
  • In sweat glands (ACh, therefore atropine blocks sweating)
  • Resistance blood vessels in skeletal muscle; activation of the sympathetic nervous system causes vasodilation in this tissue
60
Q

What is the structure of Noradrenaline?

A

Noradrenaline is a CATECHOLAMINE

61
Q

What is the synthetic pathway of tyrosine to noradrenaline?

A

Tyrosine is taken from diet

Enzyme:
- Tyrosine hydroxylase
Affect:
- Adds an OH group to form a catechole group

Resultant formed:
- L-DOPA

Enzyme:
- Dopadecarboxylase
Affect:
- Removes the carboxyl group from L-DOPA

Resultant formed:
- Dopamine

Enzyme:
- Dopaminebetahydroxylase
Affect:
- Adds a hydroxyl group to the beta carbon of dopamine

Resultant formed:
- Noradrenaline

Enzyme:
- PNMT
Affect:
- Adds a methyl group to noradrenaline

Resultant formed:
- Adrenaline

62
Q

What are false transmitters?

A

False transmitters are compounds that resemble endogenous neurotransmitters in structure but do not have the same physiological effects

False transmitters are often formed as a result of metabolic pathways being disrupted or due to the presence of certain drugs or toxins

63
Q

What are some drugs that interfere with catecholamine synthesis?

A

α methyl-tyrosine is a competitive inhibitor of tyrosine hydroxylase
used in the treatment of phaeochromocytoma

α methyl-DOPA is a drug that can be used to interfere with NAdr transmission as it leads to the synthesis of the false transmitter α methyl-NAdr

Carbidopa inhibits dopa decarboxylase (DCC) and is used in the treatment of Parkinson’s disease:
- Co-adminsteredwithL-DOPA
- StopstheperipheralmetabolismofL-DOPA
- Carbidopa doesn’tcrosstheBBB

64
Q

Where is noradrenaline stored?

A

It is stored in vesicles

Stored by a transport mechanism driven by a proton gradient

Stored with ATP and chromogranin

65
Q

What is a drug that can interfere with noradrenaline storage?

A

Reserpine is an activate compound that is isolated from a plant called Rauwolfia

Resperine inhibits the transport of presynpatic noradrenaline into vesicles

Can cause depression

66
Q

What experiment was used to measure noradrenaline uptake?

A

Iversen did an experiment to determine presence of uptake mechanisms for noradrenaline

He used radiolabelled noradrenaline

Used cardiac tissue that was receiving sympathetic innervation

He measured the amount of noradrenaline accumulated by the tissue

67
Q

What were the two uptake mechanisms that Iversen discovered for noradrenaline?

A

Uptake 1:
- High affinity
- Low capacity
- Present in nerve terminal
- Requires Na+ gradient
- ATP dependant

Uptake 2:
- Low affinity
- High capacity
- Present in extra-neuronal tissue
- Co-transport with Sodium, no energy required
- Inhibited by cortisol

68
Q

What are some drugs that block uptake 1 mechanism of noradrenaline?

A

Cocaine

Imipramine (first tricyclic antidepressants)

Desipramine

Amitryptaline

(Guanethidine weakly blocks uptake 1)

69
Q

What are some drugs that stimulate noradrenaline release?

A

Indirect sympathomimetics

Tyramine (naturally occurring in foodstuffs)

Ephedrine (used in cold remedies)

Amphetamine (psychostimulant)

70
Q

What are two important enzymes in the metabolism of noradrenaline?

A

Monoamine Oxidase (MAO)

Catechol-O-Methyl Transferase (COMT)

71
Q

What are the 2 main metabolites in noradrenaline metabolism?

A

3-methoxy-4-hydroxymandelic acid (VMA)

3-methoxy-4-hydroxyphenylglycol (MHPG)

Plasma levels of metabolites can be a useful biomarker for disease

72
Q

What is the MAO metabolic pathway of noradrenaline?

A

Noradrenaline + MAO –> Dopegal

Dopegal + AR –> DHPG

DHPG + COMT –> MHPG

MHPG + ADH –> Mopegal

Mopegal + AD –> VMA

73
Q

What is the COMT metabolic pathway of noradrenaline?

A

Noradrenaline + COMT –> Normetanephrine

Normetanephrine + MAO –> Mopegal

Mopegal + AD –> VMA

74
Q

What drugs interfere with the metabolism of noradrenaline?

A

Monoamine Oxidase Inhibitors (MAOIs)

Iproniazid

75
Q

What are the 2 subtypes of adrenoreceptors?

A

Alpha
- 2 isoforms
- Alpha1 is predominantly located in postsynaptic
- Alpha2 is predominantly located in presynaptic (inhibits neurotransmitter release)

Beta
- 3 isoforms

All are g-protein coupled receptors (GPCRS)

76
Q

What are some adrenoceptor agonists?

A

Phenylephrine (alpha 1 > alpha 2)

Methoxamine (alpha 1)

Clonidine (alpha 2)

77
Q

What are some adrenoreceptor antagonists?

A

Phentolamine (alpha 1 == alpha 2)

Phenoxybenzamine (alpha 1)

Prasozin (alpha 1 > alpha 2)

Yohimbine (alpha 2 > alpha 1)

78
Q

Beta adrenoreceptors functions

A

All are GPCRs and stimulate cAMP formation

β1
- Cardiac acceleration
- Lipolysis
- Decreased gut motility & secretion
- Renin release

β2
- Bronchodilation
- Vasodilation of blood vessels to skeletal muscle
- Glycogen breakdown

79
Q

What are some drugs used in beta adrenoreceptors?

A

Isoprenaline (beta1 > beta2)
- Used for treatment of asthma
- Associated with high incidence of heart failure

Salbutamol (beta2 > beta1)
- An effective bronchodilator by inhalation

Dobutamine (beta1 > beta2)
- Used as a cardiac stimulant

80
Q

What are some beta adrenoreceptor antagonists?

A

Propranolol
- Non-selective beta blocker
- Antihypertensive results
- Has local anaesthetic action
- Can cause bronchoconstriction

Atenolol
- Beta1 selective antagonist
- Cardioselective

81
Q

What g-proteins are associated with each type of adrenoreceptor?

A

Alpha1 = Gq

Alpha2 = Gi

Beta1,2,3 = Gs

82
Q

Overview of noradrenaline adrenoreceptor pathways

A
83
Q

What affect does the alpha 1 adrenoreceptor have on the body when bound to an agonist and an antagonist?

A

α1 (Alpha-1) Adrenoreceptor

Agonist
- Vasoconstriction (increases blood pressure)
- Mydriasis (pupil dilation)
- Increased closure of internal sphincter of the bladder

Antagonist
- Vasodilation (decreases blood pressure)
- Miosis (pupil constriction)
- Relaxation of internal sphincter of the bladder

84
Q

What affect does the alpha 2 adrenoreceptor have on the body when bound to an agonist and an antagonist?

A

α2 (Alpha-2) Adrenoreceptor

Agonist Effect
- Inhibition of norepinephrine release (negative feedback)
- Reduced insulin release, vasoconstriction in some blood vessels

Antagonist Effect:
- Increased release of norepinephrine
- Increased insulin release, potential vasodilation.

85
Q

What affect does the beta 1 adrenoreceptor have on the body when bound to an agonist and an antagonist?

A

β1 (Beta-1) Adrenoreceptor

Agonist Effect
- Increased heart rate (tachycardia)
- Increased force of heart contraction
- Increased renin release from kidneys (leading to increased angiotensin and blood pressure)

Antagonist Effect
- Decreased heart rate (bradycardia)
- Decreased force of heart contraction

86
Q
A

β2 (Beta-2) Adrenoreceptor

Agonist Effect
- Bronchodilation (opens airways)
- Vasodilation in skeletal muscle
- Increased insulin release
- Increased gluconeogenesis and glycogenolysis in liver
- Relaxation of uterine smooth muscle

Antagonist Effect:
- Bronchoconstriction (closes airways)
- Vasoconstriction in skeletal muscle
- Reduced insulin release
- Decreased gluconeogenesis and glycogenolysis

87
Q

What is the structure of acetylcholine?

A
88
Q

What is the neurotransmitter at the neuromuscular junction?

A

Acetylcholine

89
Q

What is the synthesis of acetylcholine?

A

Substrates are choline and acetylCoA

Choline is taken up into nerve terminal by choline transporter, this is the rate limiting step for synthesis

The enzyme is choline acetyltransferase (CAT)

AcetylCoA + choline –> Acetylcholine + CoA

90
Q

Packaging of acetylcholine?

A

Acetylcholine is taken up into presynaptic vesicles by an active transport process (blocked by vesamicol)

Transporter is caleld VAChT

Requires ATP

Acetylcholine is released in response calcium entry into the presynaptic terminal

91
Q

How is acetylcholine inactivated in the synaptic cleft?

A

The synaptic cleft is also rich in the enzyme Acetylcholinesterase which breaks ACh down into choline and acetic acid

Choline is taken back up into the nerve terminal by the choline transporter. This is blocked by hemicholinium.

92
Q

Acetylcholinesterase mechanism

A

Has two important sites:

Anionic site:
- Drives electrostatic interaction with the nitrogen group on acetylcholine

Esteric site
- Hydrolyses acetylcholine into choline and acetic acid

93
Q

How did Dale (1914) characterise cholinergic transmission?

A

Using:

Muscarine
Nicotine
Atropine

He found that there were two distinct types of action that can be detected:
- “Muscarine” action, which can be blocked by atropine
- “Nicotine” action, which can be blocked by excess nicotine

94
Q

What did Dale’s experiment show?

A

It showed that acetylcholine produces 2 different effects on heart rate and blood pressure based off of the concentration of acetylcholine used

The same compound triggered 2 different responses as there are 2 receptors present (muscarinic and nicotinic)

Muscarinic have high affinity meaning a only a low dose is required of ACh

Nicotinic receptors have low affinity and therefore requires high concentrations

95
Q

What is the structure of muscarine?

A
96
Q

What are some agonists of muscarinic receptors?

A
97
Q

What do agonists do on muscarinic receptors?

A

Cardiovascular:
- Decreased heartrate
- Decreased cardiac output
- Vasodilation

Gastrointestinal:
- Increased activity

Exocrine grand secretion:
- Increased sweating, lacrimation and salivation

98
Q

What are the types of muscarinic receptors?

A

M1:
- Neuronal
- Located in the CNS
- Increases IP3
- Increased DAG
- Results in gastric acid secretion and gut motility

M2:
- Cardiac
- Located in the heart (atria and presynaptic terminals)
- Decreased cAMP
- Results in cardiac inhibition and neural inhibition

M3:
- Glandular
- Located in exocrine glands, smooth muscle and vascular endothelium
- Increases IP3
- Increases DAG
- Results in secretion, smooth muscle contraction and vasodilation

99
Q

What are the 2 muscarinic receptor antagonists?

A

Atropine

Pirenzepine

100
Q

Nicotinic receptors basic structure

A

Not G-Protein coupled

All are ligand-gated ion channels and are permeable to cations

When acetylcholine binds to the receptor:
- Sodium will be imported
- Potassium will be exported
- Exchange of ions, drives downstream response

The isoform at ganglia is different from at muscle

101
Q

What are the subunits in the nicotinic receptor?

A

2 alpha
1 beta
1 delta
1 gamma

Binding site for acetylcholine is present in the alpha subunits (2 binding sites)

102
Q

What are the 2 types of nicotinic receptor?

A

Responsible for release of neurotransmitter at neuromuscular junction:
- N1 or Nm

Responsible for release of neurotransmitter at ganglia:
- N2 or Nn
- Autonomic ganglia, CNS, Adrenal medulla

103
Q

What are some nicotinic receptor agonists?

A

Acetylcholine

Nicotine

Dimethylphenylpiperazinium (DMPP)

104
Q

What is hexamethonium?

A

It is an antagonist of nicotinic receptors

It blocks ganglionic nicotinic receptors (N2 receptors)

105
Q

What are the pharmacological actions of hexamethonium?

A

Blocks the nicotinic receptor (no agonist action)

Reduces blood pressure (beneficial in hypertension)

Also causes (side effects):

  • Dry mouth
  • Reduced gastric acid secretion
  • Constipation
  • Urinary retention
  • Blurred vision
  • Postural hypertension
  • Sexual dysfunction
106
Q

What is polymethylene bismethonium series?

A

It is a family of compounds

It contains hexamethonium, the antagonist of nicotinic receptors

The image displays a generalised formula, with a variable number of carbons

Members with lower number of carbons (4-8):
- Drive ganglionic block

Members with higher numbers of carbons(7-13):
- Drive neuromuscular block

By changing number of carbons, can select different nicotinic receptor types

107
Q

What is pharmacokinetics?

A

Effect of the body on drug delivery to site of action

108
Q

What are some things that can effect pharmacokinetics?

A

Age
Dietary factors
Disease
Genetic differences
Other chemicals

109
Q

What are the 4 main pharmacokinetics processes?

A

Absorption
Distribution
Metabolism
Excretion

Metabolism & Excretion = Elimination

Rate = the speed
Extent = the amount

110
Q

What is the common relationship of drugs with regards to concentration in plasma

A

As the plasma concentration of the drug increase the response increase

The concentration of the drug in the plasma is proportional to the therapeutic effect

111
Q

What is absorption?

A

Processes that take place between the site of administration and the site of measurement

112
Q

How do drugs pass the cell membrane?

A

MEMBRANE PORES – For drugs with low molecular weights (<200Da) or small ions (Li+)

DIFFUSION THROUGH MEMBRANE – For lipid soluble molecules

CARRIER MEDIATED – Drug must resemble natural ligand or substrate

113
Q

What are some factors affecting absorption?

A
  1. LIPID SOLUBILITY
    - Rapid from gut
    - Slow from intra-muscular
  2. IONISATION OF DRUG
    - Poor for ionic drugs (from gut)
    - pH partitioning
  3. FORMULATION
    - May limit rate of absorption
    - May limit extent of absorption
  4. GASTRO-INTESTINAL FUNCTION
    - May limit rate of delivery to site of absorption
    - May limit time available for absorption
  5. FIRST-PASS METABOLISM
    - May limit extent of absorption
114
Q

What is the extent of ionisation of a drug determined by?

A

Extent of ionisation = How much of drug is in ionised form or unionised form

Determined by:
- pKa of drug
- pH of solution that drug is in

Can be calculated using the henderson-hasslebach equation

50% ionisation when pH = pKa

115
Q

What is the Henderson-Hasselbach equation

A

Used to determine the extent of ionisation of a drug

pH – pKa = log [conjugate base] / log [conjugate acid]

116
Q

what types of acid and bases can drugs be?

A

They can either be WEAK acids or WEAK bases

117
Q

What are the differences between conjugate acid and conjugate bases for drugs

A

FOR ACIDS:

Conjugate acid:
- Lipid soluble
- Crosses membranes

Conjugate base:
- Water soluble
- Does not cross membranes

FOR BASES:

Conjugate acid:
- Water soluble
- Does not cross membranes

Conjugate base:
- Lipid soluble
- Crosses membranes

ACIDS ABSORBED MORE AT HIGH pH
BASES ABSORBED MORE AT LOW pH

118
Q
A